Jie Li

机构：Tianjin Anding Hospital · ORCID：0000-0001-7156-0687

发表论文 37 篇 · 总被引 480 次 · h-index 10

代表论文

• Potential biomarker for diagnosis and therapy of sepsis: Lactylation (2023 · Immunity Inflammation and Disease · 被引 50)
• Cryptotanshinone regulates gut microbiota and PI3K-AKT pathway in rats to alleviate CUMS induced depressive symptoms (2023 · Biomedicine & Pharmacotherapy · 被引 27)
• A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer’s disease in 3xTg mice (2024 · npj Vaccines · 被引 21)
• Identifying Alzheimer’s disease and mild cognitive impairment with atlas-based multi-modal metrics (2023 · Frontiers in Aging Neuroscience · 被引 19)
• Astrocytic endothelin-1 overexpression impairs learning and memory ability in ischemic stroke via altered hippocampal neurogenesis and lipid metabolism (2023 · Neural Regeneration Research · 被引 16)
• Kaixin Jieyu Granule attenuates neuroinflammation-induced depressive-like behavior through TLR4/PI3K/AKT/FOXO1 pathway: a study of network pharmacology and experimental validation (2023 · BMC Complementary Medicine and Therapies · 被引 16)